Tracking Medicare news, policy, and coverage changes.
(MedPage Today) -- Novel in vivo CRISPR-based therapy lonvoguran ziclumeran (lonvo-z) dramatically lowered hereditary angioedema (HAE) attack frequency in the HAELO randomized trial. HAE attacks dropped by a relative 87% after the single infusion...
Read full article →Millions of dollars' worth of contraceptives meant to be distributed to low-income nations in Africa have expired, but the Trump administration is paying tens of thousands of dollars a month to keep them in storage in Belgium, according to a report from the U.S. Agency for International Development's (USAID) inspector general. About $9.7 million worth of taxpayer-funded contraceptives purchased by USAID and...
Read full article →Eli Lilly presented encouraging Phase 1 results for AJ1-11095 at the European Hematology Association (EHA) annual meeting in Stockholm. The drug, a type II JAK2 inhibitor in development for myelofibrosis, came from Lilly’s acquisition of biotech startup Ajax Therapeutics. The post Lilly’s Newly Acquired Drug Shows Promise as Next-Gen Blood Cancer Med appeared first on MedCity News .
Read full article →In the push toward a more seamless, digitally enabled future, it’s important we understand exactly how this rush to interoperability may actually harm patients, instead of helping, and what we can do to make sure they keep pace. The post Don’t Leave Healthcare’s Greatest Asset Behind on the Road to Interoperability appeared first on MedCity News .
Read full article →Once data starts moving across multiple systems, it becomes hard to track unless you’ve been very intentional about it from the start. The post Where Healthcare Data Systems Fail and How to Build Them Better appeared first on MedCity News .
Read full article →The Plausible Mechanism Framework is a breakthrough. Turning it into treatments that reach families will take five things the framework doesn’t provide. The post The FDA Opened the Door For Rare Disease Patients — Here’s What It Takes to Walk Through It appeared first on MedCity News .
Read full article →The FDA said it will allow Colorado to import certain prescription drugs from Canada in an effort to bring prices down for residents.
Read full article →After July 1, Medicare will offer GLP-1 weight-loss drugs for $50. It's supposed to be temporary, but chances are it won't be.
Read full article →A new analysis found that results for less than half of the clinical studies registered in a key European database were reported within the required time frame.
Read full article →Covid vaccination was also tied to a nearly 24% reduction in all-cause cardiac events in a large study, surprising researchers.
Read full article →A syphilis drug shortage, Sanofi's diabetes drug approval, and more biotech news from The Readout
Read full article →Pfizer hasn't complied with a request to donate emergency penicillin to state health agencies as a backstop to prevent congenital syphilis
Read full article →